Patient characteristics in the study population versus CCG 2891 population
. | AF1q study population . | Rest of CCG2891 . | P . |
|---|---|---|---|
| No. | 64 | 823 | NA |
| Median age, y | 8.5 | 7.7 | .532 |
| Median WBC count, per mm3 | 45 900 | 20 400 | .0004 |
| Male, no. (%) | 34 (53.1) | 421 (51.2) | .862 |
| Intensive induction, no. (%) | 40 (62.5) | 499 (60.6) | .871 |
| Race, overall | .289 | ||
| White, no. (%) | 47 (73) | 550 (67) | .343 |
| Nonwhite, no. (%) | 17 (27) | 273 (33) | |
| CR rate, % | 68.3 | 77.7 | .132 |
| 8-year OS from diagnosis, % | 40 | 40 | .636 |
| 8-year OS from remission, % | 48 | 52 | .445 |
. | AF1q study population . | Rest of CCG2891 . | P . |
|---|---|---|---|
| No. | 64 | 823 | NA |
| Median age, y | 8.5 | 7.7 | .532 |
| Median WBC count, per mm3 | 45 900 | 20 400 | .0004 |
| Male, no. (%) | 34 (53.1) | 421 (51.2) | .862 |
| Intensive induction, no. (%) | 40 (62.5) | 499 (60.6) | .871 |
| Race, overall | .289 | ||
| White, no. (%) | 47 (73) | 550 (67) | .343 |
| Nonwhite, no. (%) | 17 (27) | 273 (33) | |
| CR rate, % | 68.3 | 77.7 | .132 |
| 8-year OS from diagnosis, % | 40 | 40 | .636 |
| 8-year OS from remission, % | 48 | 52 | .445 |
NA indicates not applicable.